Weight management and current options in pharmacotherapy: Orlistat and Sibutramine

Keyphrases

• Weight Management 100%
• Pharmacotherapy 100%
• Orlistat 100%
• Sibutramine 100%
• Obesity 16%
• Weight Loss 16%
• Randomized Controlled Trial 16%
• Placebo 16%
• Anti-obesity 16%
• Lifestyle Intervention 8%
• Clinical Trials 8%
• Cardiovascular Risk 8%
• Obesity Management 8%
• Cardiovascular Disease 8%
• Gastrointestinal 8%
• Safety Profile 8%
• Hypertension 8%
• Evidence Support 8%
• MEDLINE 8%
• Dry Mouth 8%
• P Factor 8%
• Randomized Controlled Study 8%
• Cyclosporine 8%
• Management Strategy 8%
• Insomnia 8%
• Lifestyle Modification 8%
• Risk for Cardiovascular Diseases 8%
• Patients at Risk 8%
• Drug Interactions 8%
• Lipase 8%
• Weight Reduction 8%
• Anorexia 8%
• Obesity Treatment 8%
• Diabetic Dyslipidemia 8%
• Efficacy Profile 8%
• Maintenance Phase 8%
• Fat Absorption 8%
• Gastrointestinal Side Effects 8%
• Efficacy Trial 8%
• Hypocaloric Diet 8%
• Pharmacologic Management 8%
• Weight Regain 8%
• News Reporting 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Pharmacotherapy 100%
• Tetrahydrolipstatin 100%
• Sibutramine 100%
• Randomized Controlled Trial 16%
• Placebo 16%
• Cardiovascular Disease 16%
• Antiobesity Drugs 16%
• Clinical Trial 8%
• Cardiovascular Risk 8%
• Ciclosporin 8%
• Gastrointestinal Symptom 8%
• Dyslipidemia 8%
• Drug Interaction 8%
• Anorexia 8%
• Xerostomia 8%
• Pancreatic Lipase 8%